Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,4 USD | -0,58% | +10,32% | +23,47% |
28/03 | CELLECTAR BIOSCIENCES, INC. : Roth MKM handhaaft koopadvies | ZM |
28/03 | CELLECTAR BIOSCIENCES, INC. : Oppenheimer handhaaft koopadvies | ZM |
Vakgebied
Aantal werknemers: 20
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James V. Caruso
CEO | Chief Executive Officer | 65 | 15-06-15 |
Chad J. Kolean
DFI | Director of Finance/CFO | 59 | 28-05-14 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-23 |
Jarrod Longcor
COO | Chief Operating Officer | 51 | 15-07-16 |
Shane Lea
PRN | Corporate Officer/Principal | - | 21-11-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 07-04-17 |
Douglas Swirsky
CHM | Chairman | 54 | 07-04-17 |
John Neis
BRD | Director/Board Member | 68 | 01-02-08 |
James V. Caruso
CEO | Chief Executive Officer | 65 | 15-06-15 |
Stefan Loren
BRD | Director/Board Member | 60 | 15-06-15 |
Director/Board Member | 55 | 24-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 320 | 0 | 0 | 88,19 % |
Aandeel B | 0 | 111 | 0 | 0 | |
Aandeel C | 0 | 1 237 | 0 | 0 | |
Aandeel D | 1 | 32 260 510 | 28 450 306 ( 88,19 %) | 0 |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,47% | 123 mln. | |
+28,50% | 662 mld. | |
+22,23% | 546 mld. | |
-4,93% | 359 mld. | |
+16,97% | 323 mld. | |
+4,08% | 289 mld. | |
+13,68% | 234 mld. | |
+3,84% | 198 mld. | |
-10,35% | 194 mld. | |
+3,98% | 167 mld. |
- Beurs
- Aandelen
- Koers CLRB
- Onderneming Cellectar Biosciences, Inc.